We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

EA:NASDAQElectronic Arts Inc. Analysis

Data as of 2026-03-30 - not real-time

$202.38

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

Electronic Arts is trading near a technical resistance level while the MACD shows a bullish crossover. The RSI sits in a neutral zone, indicating no immediate overbought pressure. Volume has been tapering, which tempers the bullish signal. A discounted cash‑flow model places the intrinsic value modestly below the market price, suggesting limited upside. The trailing price‑to‑earnings multiple is markedly higher than the sector average, flagging overvaluation. Forward earnings estimates compress the multiple but it remains elevated, and revenue growth is modest.
The company’s balance sheet is strong with ample cash and a manageable debt load, supporting its dividend. The dividend payout ratio is well under one‑third, making the payout sustainable. Beta is low, providing defensive characteristics in a volatile market. Gaming faces regulatory scrutiny, placing medium regulatory risk on the business. Geographic exposure is concentrated in the United States, keeping geographic risk low. Overall, the mix of modest growth prospects, high valuation and defensive fundamentals leads to a hold recommendation across horizons.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD histogram indicating momentum
  • Price approaching key resistance level
  • Decreasing volume suggesting caution

Medium Term

1–3 years
Neutral
Model confidence: 5/10

Key Factors

  • Forward earnings estimates imply earnings growth
  • Valuation remains above fair value
  • Strong cash generation supports operations

Long Term

> 3 years
Neutral
Model confidence: 5/10

Key Factors

  • Robust subscription and live‑service pipeline
  • Sustainable dividend policy
  • Low beta and defensive cash position

Key Metrics & Analysis

Financial Health

Revenue Growth1.00%
Profit Margin9.31%
P/E Ratio75.8
ROE10.03%
ROA4.81%
Debt/Equity36.44
P/B Ratio8.2
Op. Cash Flow$2.5B
Free Cash Flow$2.2B
Industry P/E16.7

Technical Analysis

TrendNeutral
RSI58.9
Support$197.01
Resistance$202.62
MA 20$200.64
MA 50$201.34
MA 200$187.34
MACDBullish
VolumeDecreasing
Fear & Greed Index67.46

Valuation

Fair Value$125.22
Target Price$207.94
Upside/Downside2.75%
GradeOvervalued
TypeGrowth
Dividend Yield0.38%

Risk Assessment

Beta0.33
Volatility6.44%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskMedium

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.